Clinical Trial Update: Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and tolerability of a single intravenous infusion of BX-U001 in patients with refractory rheumatoid arthritis. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BX-U001 (Human umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Baylx Inc. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: NOT_YET_RECRUITING